Browse > Article
http://dx.doi.org/10.7778/jpkm.2022.36.3.87

Anti-inflammatory Effect of Sabaek-san Extract through ECS Control in Atopic Dermatitis  

Ahn, Sang Hyun (Dept. of anatomy, College of Korean Medicine, Semyung University)
Jeong, A Ram (Dept. of Pediatrics, College of Korean Medicine, Gachon University)
Kim, Ki Bong (School of Korean Medicine, Pusan National University)
Publication Information
The Journal of Pediatrics of Korean Medicine / v.36, no.3, 2022 , pp. 87-96 More about this Journal
Abstract
Objective The purpose of this study was to confirm the effect of Sabaek-san extract on skin damage recovery and inflammation relief in atopic dermatitis-induced mice through Endocannabinoid system (ECS) control. Methods In this study, we used 6-week-old NC/Nga mice were divided into 4 group: control group (Ctrl), lipid barrier elimination group (LBEG), palmitoylethanolamide (PEA) treated group after lipid barrier elimination (PEAG), and Sabaek-san extract treatment group after lipid barrier elimination (SBSG). Each group was assigned 10 animals. After drug administration of three weeks duration following lipid barrier elimination, cannabinoid receptor (CB) 1, CB2, CD (Cluster of Differentiation) 68, phosphorylated inhibitor kappa B (p-IκB), inducible nitric oxide synthase (iNOS), Fc ε receptor, substance P and serotonin were observed to confirm the regulation of the ECS, macrophage activity and mast cell activity. Results We found that 8-hydroxydeoxyguanosine (8-OXdG) positive reaction was significantly lower in the SBST group than in LBET and PEAT groups. Both CB1 and CB2 showed higher positive reactions in the SBST group than in the LBET and PEAT. CD68, p-IκB, iNOS, Fc ε receptor, Substance P and serotonin showed lower positive reaction in the SBST compared to the LBET and PEAT. Conclusion It was confirmed that the Sabaek-san extract can reduce the inflammation of atopic dermatitis by restoring the structural damage of the skin lipid barrier through ECS activity.
Keywords
Sabaek-san; Atopic Dermatitis; Endocannabinoid system (ECS); Inflammation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Kim JH. Current understanding of atopic dermatitis. Pediatr Allergy Respir Dis. 2004;14(1):12-23.
2 Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, Novak N, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nicklas R, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295-9.   DOI
3 Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England). 2016;387(10023):1109-22.   DOI
4 Jee HM, Kim KW, Kim CS, Sohn MH, Shin DC, Kim KE. Prevalence of asthma, rhinitis and eczema in Korean children using the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires. Pediatr Allergy Respir Dis. 2009;19(2):165-72.
5 Im GM, Joeng HW, Kim HS, Jeong WY. Oriental medical approach on the allergic disease. Korea J Oriental Physiology & Pathology. 2002;16(5):831-9.
6 Kim MJ, Lee SY. A literature study of atopic dermatitis for children. J Pediatr Korean Med. 2000;14(2):167-82.
7 Heo J. Donguibogam. 4th ed. Seoul: Namsandang. 1994:145.
8 Ahn SH, Jeong AR, Kim KB. Th2 differentiation control through formation of skin fat barrier of Sabaek-san extract. J Pediatr Korean Med. 2022;36(1):57-64.
9 Toth KF, Adam D, Biro T, Olah A. Cannabinoid signaling in the skin: therapeutic potential of the "c(ut)annabinoid" system. Molecules. 2019;24(5):918.   DOI
10 Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med. 2002;30(1) Suppl:74-9.
11 Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87(1):13-20.   DOI
12 Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sciences. 2004;75(6):639-53.   DOI
13 Lee HJ. Effects of Sabaek-san on the metrix metalloproteinase-9 in the bronchial asthma mouse model. JPPKM. 2004;18(6):1694-8.
14 Kang MY, Jang GT, Kim JH. A study on fetal toxicosis removal therapy. J Pediatr Korean Med. 2003;17(1):29-51.
15 Lee HJ. Effects of Sabaek-san on the metrix metalloproteinase-9 in the bronchial asthma mouse model. JPPKM. 2004;18(6):1694-8.
16 Korean Medical Pharmacology Text Publication Committee. Korean medical pharmacology. 3rd ed. Seoul: Shinil Books. 2010:116-249.
17 Salzet M. Invertebrate molecular neuroimmune processes. Brain Res Rev, 2000;34(1):69-79.   DOI
18 Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462.   DOI
19 Kupczyk P, Reich A, Szepietowski JC. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol. 2009;18(8):669-79.   DOI
20 Maccarrone M, Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A. The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem. 2003;278(36):33896-903.   DOI
21 Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science. 2007;316(5830):1494-7.   DOI
22 Piazza PV, Lafontan M, Girard J. Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system. Diabetes Metab. 2007;33(2):97-107.   DOI
23 Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol. 2005;168:509-54.   DOI
24 Park SH, Park HJ. Root bark extract of Morus alba L. suppressed the migration and invasion of HCT116 human colorectal carcinoma cells. JPPKM. 2021;35(5):177-84.   DOI
25 Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151-60.   DOI
26 Zheng T, Yu JH, Oh MH, Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3(2):1052242
27 Ahn KM, Kim JH, Kwon HJ, Chae YM, Hahm MI, Lee KJ, Park YM, Lee SY, Han MY, Kim WK. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc. 2011;54(7):769-78.   DOI
28 Lee DS, Choi HG, Kim KS, Kim DC, Min HK, Li B, Park JH, Oh HC, Kim YC. The comparison between Sabaek-san water and 30% EtOH extracts for anti-inflammatory effects. Yahak Hoeji. 2012;56(4): 240-7.
29 Baron ED, Barzilai D, Johnston G, Kawashima M, Takigawa M, Nakagawa H, Graham-Browh R. Stevens SR. Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K. Br J Dermatol. 2002;147:710-5.   DOI
30 Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev. 2011;63(3):461-70.   DOI
31 Luger TA. Neuromediators--a crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87-93.   DOI
32 Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344(1):30-7.   DOI
33 Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 2003;111(1):43-50.   DOI
34 Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol. 2007;152(5):624-32.   DOI
35 Chung, HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009;8(1):18-30.   DOI